CU23358B7 - Vacuna que comprende una proteína cemento de garrapata - Google Patents

Vacuna que comprende una proteína cemento de garrapata

Info

Publication number
CU23358B7
CU23358B7 CU20020238A CU20020238A CU23358B7 CU 23358 B7 CU23358 B7 CU 23358B7 CU 20020238 A CU20020238 A CU 20020238A CU 20020238 A CU20020238 A CU 20020238A CU 23358 B7 CU23358 B7 CU 23358B7
Authority
CU
Cuba
Prior art keywords
vaccine
garrapata
cement protein
ectoparasites
cement proteins
Prior art date
Application number
CU20020238A
Other languages
English (en)
Inventor
Guido Christiaan Paesen
Adama Roseanne Trimnell
Patricia Anne Nuttall
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of CU23358B7 publication Critical patent/CU23358B7/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0003Invertebrate antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Insects & Arthropods (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere al uso de proteínas cemento de garrapatas en la producción de vacunas para proteger animales contra la picadura de ectoparásitos que se alimentan de sangre y contra la transmisión de virus, bacterias y otros patógenos por tales ectoparásitos. Cuando se usan como componentes de vacunas, la proteína cemento de garrapata de la invención confiere amplia reactividad recíproca contra una variedad de especies de ectoparásitos.
CU20020238A 2000-04-25 2002-04-25 Vacuna que comprende una proteína cemento de garrapata CU23358B7 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0010068.5A GB0010068D0 (en) 2000-04-25 2000-04-25 Vaccine composition
GBGB0028606.2A GB0028606D0 (en) 2000-04-25 2000-11-23 Vaccine composition

Publications (1)

Publication Number Publication Date
CU23358B7 true CU23358B7 (es) 2009-03-16

Family

ID=9890483

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20020238A CU23358B7 (es) 2000-04-25 2002-04-25 Vacuna que comprende una proteína cemento de garrapata

Country Status (5)

Country Link
JP (1) JP4925236B2 (es)
CN (1) CN101406696A (es)
AT (1) ATE551068T1 (es)
CU (1) CU23358B7 (es)
GB (2) GB0010068D0 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110540583B (zh) * 2018-05-29 2022-07-15 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 镰形扇头蜱液泡分拣蛋白分子及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723945D0 (en) * 1997-11-12 1998-01-07 Nat Environmental Research Cou Tissue cement

Also Published As

Publication number Publication date
GB0028606D0 (en) 2001-01-10
GB0010068D0 (en) 2000-06-14
JP2003531177A (ja) 2003-10-21
CN101406696A (zh) 2009-04-15
ATE551068T1 (de) 2012-04-15
JP4925236B2 (ja) 2012-04-25

Similar Documents

Publication Publication Date Title
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
WO2004030608A3 (en) Nanoemulsion vaccines
EP1499191A4 (en) REGULATED ATTENUATION OF LIVE VACCINES TO ENHANCE CROSS-PROTECTIVE IMMUNOGENICITY
DK1326633T3 (da) Sammensætning omfattende immunogene mikropartikler
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
NO20034244D0 (no) Mikrobielt fôr for akvakultur og landbruk
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
BR0110278A (pt) Composição de vacina, anticorpo ou anti-soro, métodos de produção de um anticorpo ou de um anti-soro e de imunização de um animal contra um ectoparasita que se alimenta de sangue, proteìna de cemento de carrapato, e, uso de uma proteìna de cemento de carrapato
WO2005035558A3 (en) Piscirickettsia salmonis antigens and use thereof
DK1471936T3 (da) HIV-Vaccine og fremgangsmåde til anvendelse
ATE413888T1 (de) Salmonella vakzine
MXPA03006971A (es) Tratamiento del virus de hepatitis b.
WO2004043404A3 (en) Process for designing inhibitors of influenza virus non-structural protein 1
ATE349520T1 (de) Gewebezementproteine aus rhipicephalus appendiculatus
CU23358B7 (es) Vacuna que comprende una proteína cemento de garrapata
EA200301151A1 (ru) Вакцина против натуральной оспы
NO20062469L (no) Streptococcus phocae vaksine
ATE487489T1 (de) Rekombinante intrazellulärepathogen-immunogene zusammensetzungen und anwendungsverfahren
DE60238554D1 (de) Vakzine gegen infektionskrankheiten
WO2004082596A3 (en) Yersinia species compositions
DK1074266T3 (da) Levende svækkede bakterier til anvendelse i vaccine
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
CY1107374T1 (el) Εμβολιο ιχθυος εναντι της piscirickettsia salmonis
ATE495757T1 (de) Attenuierte bakterielle lebendvakzine
WO2004009764A3 (en) Methods and compositions concerning altered yellow fever virus strains